Related references
Note: Only part of the references are listed.Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice
Mehran Ghasemzadeh et al.
HUMAN IMMUNOLOGY (2022)
A robust platform for expansion and genome editing of primary human natural killer cells
Rih-Sheng Huang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Human NK cells: From development to effector functions.
Arosh Shavinda Perera Molligoda Arachchige
INNATE IMMUNITY (2021)
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia
C. Quintarelli et al.
LEUKEMIA (2020)
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy
Emily J. Pomeroy et al.
MOLECULAR THERAPY (2020)
Arti ficial feeder cells expressing ligands for killer cell immunoglobulin- like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self
Susanne Michen et al.
CYTOTHERAPY (2020)
NK cells mediate clearance of CD8(+) T cell-resistant tumors in response to STING agonists
Christopher J. Nicolai et al.
SCIENCE IMMUNOLOGY (2020)
Evaluation of serum -free media formulations in feeder cell stimulated expansion of natural killer cells
Jena E. Moseman et al.
CYTOTHERAPY (2020)
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy
Frank Cichocki et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
Evelyn O. Ojo et al.
SCIENTIFIC REPORTS (2019)
Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy
Bokyung Min et al.
IMMUNE NETWORK (2018)
Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies
Paulina Nowakowska et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
LFA-1 Activation in NK Cells and Their Subsets: Influence of Receptors, Maturation, and Cytokine Stimulation
Doris Urlaub et al.
JOURNAL OF IMMUNOLOGY (2017)
NK cell-based immunotherapy for cancer
Fang Fang et al.
SEMINARS IN IMMUNOLOGY (2017)
Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function
John P. Veluchamy et al.
SCIENTIFIC REPORTS (2017)
Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property
Maria Delso-Vallejo et al.
FRONTIERS IN IMMUNOLOGY (2017)
A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma
Juliane Wagner et al.
FRONTIERS IN IMMUNOLOGY (2017)
Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody
Hong-Rae Lee et al.
SCIENTIFIC REPORTS (2017)
Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation
Brian C. Shaffer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells
Hans Klingemann et al.
FRONTIERS IN IMMUNOLOGY (2016)
Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach
Jeremiah L. Oyer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Expansion of NK cells from PBMCs using immobilized 4-1BBL and interleukin-21
Xiaomei Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer
Naoyuki Sakamoto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Human platelet lysate successfully promotes proliferation and subsequent chondrogenic differentiation of adipose-derived stem cells: a comparison with articular chondrocytes
F. Hildner et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2015)
A Novel Method for Assessment of Natural Killer Cell Cytotoxicity Using Image Cytometry
Srinivas S. Somanchi et al.
PLOS ONE (2015)
NK Cells with KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival
Andrea Gras Navarro et al.
JOURNAL OF IMMUNOLOGY (2014)
Optimizing the production of suspension cells using the G-Rex M series
Pradip Bajgain et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo
Okjae Lim et al.
PLOS ONE (2013)
Human-Derived Alternatives to Fetal Bovine Serum in Cell Culture
Karin Witzeneder et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2013)
Therapeutic applications: natural killer cells in the clinic
Jeffrey S. Miller
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
Natalia Lapteva et al.
CYTOTHERAPY (2012)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
Srinivas S. Somanchi et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
Tolga Sutlu et al.
CYTOTHERAPY (2010)
Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
Maria Berg et al.
CYTOTHERAPY (2009)
Structure of Natural Killer Cell Receptor KLRG1 Bound to E-Cadherin Reveals Basis for MHC-Independent Missing Self Recognition
Yili Li et al.
IMMUNITY (2009)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells
T Igarashi et al.
BLOOD (2004)
Share Paper
